Onchocerciasis-Associated Epilepsy

Scientific publications on Onchocerciasis-Associated Epilepsy (OAE) - Global Health Institute

OAE-related Academic Publications

Explore the scholarly studies and articles on onchocerciasis-associated epilepsy (OAE).

  • Bhwana D. Onchocerciasis-associated epilepsy in the Mahenge area, Tanzania. PhD Thesis, University of Antwerp.
  • Bhwana D, Siewe Fodjo JN, Amaral LJ, Vandevenne L, Francis F, Challe DP, Mmbando BP, Colebunders R.Disability assessment among persons with epilepsy in Mahenge, an onchocerciasis-endemic area in Tanzania: A cross-sectional study. Epilepsy Behav. 2023 Sep;146:109367. doi: 10.1016/j.yebeh.2023.109367.
  • Jada SR, Amaral LJ, Lakwo T, Carter JY, Rovarini J, Bol YY, Logora MY, Hadermann A, Hopkins A, Fodjo JNS, Colebunders R. Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study. Lancet Glob Health. 2023 Aug;11(8):e1260-e1268. doi: 10.1016/S2214-109X(23)00248-6.
  • Colebunders R, Hadermann A, Siewe Fodjo JN. The onchocerciasis hypothesis of nodding syndrome.PLoS Negl Trop Dis. 2023 Aug 17;17(8):e0011523. doi: 10.1371/journal.pntd.0011523.
  • Otabil KB, Ankrah B, Bart-Plange EJ, Donkoh ES, Avarikame FA, Ofori-Appiah FO, Babae TN, Kudzordzi PC, Darko VA, Ameyaw J, Bamfo JG, Sakibu RA, Antwi-Berko D, Fodjo JNS, Basáñez MG, Schallig HDFH, Colebunders R. Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin. Infect Dis Poverty. 2023 Aug 17;12(1):75. doi: 10.1186/s40249-023-01117-9.
  • Siewe Fodjo JN, Van Cutsem G, Amaral LJ, Colebunders R. Mortality among persons with epilepsy in onchocerciasis-endemic and non-endemic areas of sub-Saharan Africa: A systematic review and meta-analysis. Seizure. 2023 Aug;110:253-261. doi: 10.1016/j.seizure.2023.07.006.
  • Bhwana D, Amaral LJ, Mhina A, Hayuma PM, Francis F, Siewe Fodjo JN, Mmbando BP, Colebunders R.Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study. PLoS Negl Trop Dis. 2023 Jun 28;17(6):e0011178. doi: 10.1371/journal.pntd.0011178. 
  • Amaral LJ, Bhwana D, Fomo MF, Mmbando BP, Chigoho CN, Colebunders R. Quality of life of persons with epilepsy in Mahenge, an onchocerciasis-endemic area in Tanzania: A cross-sectional study. Epilepsy Behav. 2023 Aug;145:109302. doi: 10.1016/j.yebeh.2023.109302.
  • Lakwo, T. L.and R. Colebunders. The Role of Entomology in Onchocerciasis Elimination. University of Antwerp, Department of Epidemiology and Social Medicine, Global Health Institute, 2023.
  • Amaral, L.-J., et al. “Nodding Syndrome, a Case-control Study in Mahenge, Tanzania : Onchocerca volvulus and Not Mansonella perstans as a Risk Factor”. Plos Neglected Tropical Diseases, vol. 17, no. 6, 2023, pp. 1–7, https://doi.org/10.1371/JOURNAL.PNTD.0011434 .
  • https://doi.org/10.1371/JOURNAL.PNTD.0011178 .
  • Bhattacharyya, S., et al. “Onchocerciasis-associated Epilepsy in Maridi, South Sudan : Modelling and Exploring the Impact of Control Measures Against River Blindness”. Plos Neglected Tropical Diseases, vol. 17, no. 5, 2023, pp. 1–7, https://doi.org/10.1371/JOURNAL.PNTD.0011320 .
  • Van Cutsem G, Siewe Fodjo JN, Dekker MCJ, Amaral LJ, Njamnshi AK, Colebunders R. Case definitions for onchocerciasis-associated epilepsy and nodding syndrome: A focused review. Seizure. 2023 Apr;107:132-135. doi: 10.1016/j.seizure.2023.03.024.
  • Post, R. J., et al. “Identification of the Onchocerciasis Vector in the Kakoi-koda Focus of the Democratic Republic of Congo”. Plos Neglected Tropical Diseases, vol. 16, no. 11, 2022, pp. 1–7, https://doi.org/10.1371/JOURNAL.PNTD.0010684 .
  • Abd-Elfarag, G. O. E., et al. “Nodding Syndrome : Clinical Characteristics, Risks Factors, Access to Treatment, and Perceptions in the Greater Mundri Area, South Sudan”. Pathogens, vol. 12, no. 2, 2023, pp. 1–8, https://doi.org/10.3390/PATHOGENS12020190 .
  • Van Cutsem, G.and R. Colebunders. “How to Decrease the Epilepsy Disease Burden in Sub-saharan Africa?”. Epilepsy and Behavior, vol. 139, 2023, pp. 1–2, https://doi.org/10.1016/J.YEBEH.2022.109052 .
  • Bhwana, D., et al. “Ivermectin Treatment Response in Two Rural Villages with a High Prevalence of Onchocerciasis and Epilepsy, Mahenge Tanzania”. African Health Sciences, vol. 22, no. 3, 2022, pp. 607–16, https://doi.org/10.4314/AHS.V22I3.65 .
  • Gumisiriza, N.and R. Colebunders. From Nodding Syndrome to Onchocerciasis Associated Epilepsy : Epidemiological Studies in Uganda. University of Antwerp, Faculty of Medicine and Health Sciences, Department of Epidemiology and Social Medicine, 2022.
  • Otiti-Sengeri, J., et al. “High Prevalence of Glaucoma Among Patients in an Onchocerciasis Endemic Area (mahenge, Tanzania)”. Pathogens, vol. 11, no. 9, 2022, pp. 1–0, https://doi.org/10.3390/PATHOGENS11091046 .
  • Dusabimana, A., et al. Ways to Mitigate the Public Health Problem Caused by Onchocerciasis-associated Epilepsy. Edited by Robert Colebunders, University of Antwerp, Faculty of Medicine and Health Sciences, Department of Family Medicine and Population Health, 2022.
  • Colebunders, R., et al. “Reducing Onchocerciasis-associated Morbidity in Onchocerciasis-endemic Foci with High Ongoing Transmission : A Focus on the Children”. International Journal of Infectious Diseases, vol. 116, 2022, pp. 302–05, https://doi.org/10.1016/J.IJID.2022.01.042 .
  • Yengo, B. N., et al. “Immunoinformatics Design and Assessment of a Multiepitope Antigen (ovmcbl02) for Onchocerciasis Diagnosis and Monitoring”. Diagnostics, vol. 12, no. 6, 2022, pp. 1–5, https://doi.org/10.3390/DIAGNOSTICS12061440 .
  • Erber, A. C.and R. Colebunders. “Ivermectin for Malaria Control in Mass Drug Administration Programmes”. The Lancet Infectious Diseases, vol. 22, no. 4, 2022, pp. 449–50, https://doi.org/10.1016/S1473-3099(22)00152-9 .
  • Irani, J., et al. “'there Were Moments We Wished She Could Just Die' : The Highly Gendered Burden of Nodding Syndrome in Northern Uganda”. Qualitative Health Research, vol. 32, no. 10, 2022, pp. 1544–56, https://doi.org/10.1177/10497323221085941 .
  • Jada, S. R., et al. “The Prevalence of Onchocerciasis-associated Epilepsy in Mundri West and East Counties, South Sudan : A Door-to-door Survey”. Pathogens, vol. 11, no. 4, 2022, pp. 1–7, https://doi.org/10.3390/PATHOGENS11040396 .
  • Dolo, H., et al. “Prevalence and Risk Factors Associated with Epilepsy in Six Health Districts of Mali : A Community-based Cross-sectional and Nested Case-control Study”. Neuroepidemiology, vol. 56, no. 2, 2022, pp. 127–37, https://doi.org/10.1159/000522021 .
  • Dusabimana, A., et al. “Surveillance for Onchocerciasis-associated Epilepsy and OV16 Igg4 Testing of Children 6-10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening”. Pathogens, vol. 11, no. 3, 2022, pp. 1–6, https://doi.org/10.3390/PATHOGENS11030281 .
  • Siewe Fodjo, J. N., et al. “'slash and Clear' Vector Control for Onchocerciasis Elimination and Epilepsy Prevention : A Protocol of a Cluster Randomised Trial in Cameroonian Villages”. BMJ Open, vol. 11, no. 9, 2021, pp. 1–0, https://doi.org/10.1136/BMJOPEN-2021-050341 .
  • Mmbando, B. P., et al. “Community Knowledge, Attitudes, and Practices Regarding Epilepsy in Mahenge, Tanzania : A Socio-anthropological Study in an Onchocerciasis-endemic Area with a High Prevalence of Epilepsy”. Epilepsy and Behavior, vol. 128, 2022, https://doi.org/10.1016/J.YEBEH.2022.108568 .
  • Boven, A. G., et al. “Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection”. Open Forum Infectious Diseases, vol. 8, no. 12, 2021, pp. 1–3, https://doi.org/10.1093/OFID/OFAB456 .
  • Jada, S. R., et al. “Community Perception of Epilepsy and Its Treatment in Onchocerciasis-endemic Villages of Maridi County, Western Equatoria State, South Sudan”. Epilepsy and Behavior, vol. 127, 2022, https://doi.org/10.1016/J.YEBEH.2021.108537 .
  • Gumisiriza, N., et al. “Risk Factors for Nodding Syndrome and Other Forms of Epilepsy in Northern Uganda : A Case-control Study”. Pathogens, vol. 10, no. 11, 2021, https://doi.org/10.3390/PATHOGENS10111451 .
  • Erber, A. C., et al. “Treatment of Pregnant Women with Ivermectin During Mass Drug Distribution : Time to Investigate Its Safety and Potential Benefits”. Pathogens, vol. 10, no. 12, 2021, pp. 1–8, https://doi.org/10.3390/PATHOGENS10121588 .
  • Shintouo, C. M., et al. “Tandem Use of Ovmane1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis”. Life, vol. 11, no. 12, 2021, https://doi.org/10.3390/LIFE11121284 .
  • Hendy, A., et al. “Onchocerca Volvulus Transmission in the Mbam Valley of Cameroon Following 16 Years of Annual Community-directed Treatment with Ivermectin, and the Description of a New Cytotype of Simulium Squamosum”. Parasites and Vectors, vol. 14, no. 1, 2021, https://doi.org/10.1186/S13071-021-05072-Y .
  • Raimon, S., et al. “"slash and Clear", a Community-based Vector Control Method to Reduce Onchocerciasis Transmission by Simulium Sirbanum in Maridi, South Sudan : A Prospective Study”. Pathogens, vol. 10, no. 10, 2021, https://doi.org/10.3390/PATHOGENS10101329 .
  • Bhwana, D., et al. “A Peer Support Group Intervention to Decrease Epilepsy-related Stigma in an Onchocerciasis-endemic Area in Mahenge, Tanzania : A Pilot Study”. Epilepsy and Behavior, vol. 124, 2021, https://doi.org/10.1016/J.YEBEH.2021.108372 .
  • Siewe Fodjo, J. N., et al. “Association Between Ov16 Seropositivity and Neurocognitive Performance Among Children in Rural Cameroon : A Pilot Study”. Journal of Pediatric Neuropsychology, vol. 7, no. 4, 2021, pp. 192–202, https://doi.org/10.1007/S40817-021-00111-Z .
  • Morin, A., et al. “Epilepsy in the Sanaga-mbam Valley, an Onchocerciasis-endemic Region in Cameroon : Electroclinical and Neuropsychological Findings”. Epilepsia Open, vol. 6, no. 3, 2021, pp. 513–27, https://doi.org/10.1002/EPI4.12510 .
  • Roach, M., et al. “No Evidence Known Viruses Play a Role in the Pathogenesis of Onchocerciasis-associated Epilepsy : An Explorative Metagenomic Case-control Study”. Pathogens, vol. 10, no. 7, 2021, https://doi.org/10.3390/PATHOGENS10070787 .
  • Hotterbeekx, A., et al. “No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-associated Epilepsy”. Pathogens, vol. 10, no. 7, 2021, https://doi.org/10.3390/PATHOGENS10070845 .
  • Metanmo, S., et al. “First Description of Nodding Syndrome in the Central African Republic”. Plos Neglected Tropical Diseases, vol. 15, no. 6, 2021, https://doi.org/10.1371/JOURNAL.PNTD.0009430 .
  • Vieri, M. K., et al. “Serotonin Levels in the Serum of Persons with Onchocerciasis-associated Epilepsy : A Case-control Study”. Pathogens, vol. 10, no. 6, 2021, https://doi.org/10.3390/PATHOGENS10060720 .
  • Vieri, M. K., et al. “The World Health Organization Road Map for Neglected Tropical Diseases 2021-2030 : Implications for Onchocerciasis Elimination Programs”. Infectious Diseases of Poverty, vol. 10, no. 1, 2021, https://doi.org/10.1186/S40249-021-00848-X.
  • Dolo, H., et al. “Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali”. Clinical Infectious Diseases, vol. 72, no. 9, 2021, pp. 1585–93, https://doi.org/10.1093/CID/CIAA318 .
  • Kaiser, C., et al. “Case Report : Nakalanga Syndrome Revisited: Long-term Follow-up of a Patient Living in Western Uganda, 1994 - 2018”. The American Journal of Tropical Medicine and Hygiene, vol. 104, no. 3, 2021, pp. 902–06, https://doi.org/10.4269/AJTMH.20-0979 .
  • Raimon, S., et al. “High Prevalence of Epilepsy in an Onchocerciasis-endemic Area in Mvolo County, South Sudan : A Door-to-door Survey”. Pathogens, vol. 10, no. 5, 2021, https://doi.org/10.3390/PATHOGENS10050599 .
  • Gumisiriza, N., et al. Nodding Syndrome, Many Questions Remain but We Can Prevent It by Eliminating Onchocerciasis. no. 1, 2021, https://doi.org/10.1093/BRAINCOMMS/FCAA228 .
  • Hotterbeekx, A., et al. “Onchocerciasis Prevalence Among Persons with Epilepsy in an Onchocerciasis Hypo-endemic Area in the Democratic Republic of Congo : A Cross-sectional Study”. Pathogens, vol. 10, no. 4, 2021, https://doi.org/10.3390/PATHOGENS10040389 .
  • Hotterbeekx, A., et al. “The Secretome of Filarial Nematodes and Its Role in Host-parasite Interactions and Pathogenicity in Onchocerciasis-associated Epilepsy”. Frontiers in Cellular and Infection Microbiology, vol. 11, 2021, https://doi.org/10.3389/FCIMB.2021.662766 .
  • Vieri, M. K., et al. “Cytokines and Onchocerciasis-associated Epilepsy, a Pilot Study and Review of the Literature”. Pathogens, vol. 10, no. 3, 2021, https://doi.org/10.3390/PATHOGENS10030310 .
  • Vieri, M. K., et al. “Nodding Syndrome Research Revisited”. International Journal of Infectious Diseases, vol. 104, 2021, pp. 739–41, https://doi.org/10.1016/J.IJID.2021.02.006 .
  • Vieri, M. K., et al. “Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo”. Pathogens, vol. 10, no. 3, 2021, https://doi.org/10.3390/PATHOGENS10030359 .
  • Hotterbeekx, A., et al. “Neuropathological Changes in Nakalanga Syndrome : A Case Report”. Pathogens, vol. 10, no. 2, 2021, https://doi.org/10.3390/PATHOGENS10020116 .
  • Ronse, M., et al. “In Pursuit of a Cure : The Plural Therapeutic Landscape of Onchocerciasis-associated Epilepsy in Cameroon - a Mixed Methods Study”. Plos Neglected Tropical Diseases, vol. 15, no. 2, 2021, https://doi.org/10.1371/JOURNAL.PNTD.0009206 .
  • Dusabimana, A., et al. “Community Perceptions and Attitudes Regarding Epilepsy and Disease Cost After Implementation of a Community-based Epilepsy Treatment Program in Onchocerciasis-endemic Communities in the Democratic Republic of Congo”. Epilepsy and Behavior, vol. 116, 2021, https://doi.org/10.1016/J.YEBEH.2021.107773 .
  • Dusabimana, A., et al. “Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca Volvulus”. Pathogens, vol. 10, no. 1, 2021, https://doi.org/10.3390/PATHOGENS10010021 .
  • Colebunders, R., et al. “Onchocerca Volvulus and Epilepsy : A Comprehensive Review Using the Bradford Hill Criteria for Causation”. Plos Neglected Tropical Diseases, vol. 15, no. 1, 2021, https://doi.org/10.1371/JOURNAL.PNTD.0008965 .
  • Jada, S. R., et al. “Epilepsy-related Stigma and Cost in Two Onchocerciasis-endemic Areas in South Sudan : A Pilot Descriptive Study”. Seizure: European Journal of Epilepsy, vol. 81, 2020, pp. 151–56, https://doi.org/10.1016/J.SEIZURE.2020.08.003 .
  • Siewe Fodjo, J. N., et al. “Meta-analysis of Epilepsy Prevalence in West Africa and Its Relationship with Onchocerciasis Endemicity and Control”. International Health, vol. 12, no. 3, 2020, pp. 192–202, https://doi.org/10.1093/INTHEALTH/IHAA012 .
  • Gumisiriza, N., et al. “Changes in Epilepsy Burden After Onchocerciasis Elimination in a Hyperendemic Focus of Western Uganda : A Comparison of Two Population-based, Cross-sectional Studies”. The Lancet Infectious Diseases, vol. 20, no. 11, 2020, pp. 1315–23, https://doi.org/10.1016/S1473-3099(20)30122-5 .
  • Mandro Ndahura, M., et al. Epilepsy in Onchocerciasis Endemic Villages of Democratic Republic of Congo : Epidemiology, Clinical and Treatment Aspects. University of Antwerp, Faculty of Medicine & Health sciences, 2020.
  • Dusabimana, A., et al. “OV16 Seroprevalence Among Persons with Epilepsy in Onchocerciasis Endemic Regions : A Multi-country Study”. Pathogens, vol. 9, no. 10, 2020, https://doi.org/10.3390/PATHOGENS9100847 .
  • de Merxem, D. G., et al. “Nodding Syndrome Research, Lessons Learned from the NSETHIO Project”. Global Mental Health, vol. 6, 2019, https://doi.org/10.1017/GMH.2019.24 .
  • Hotterbeekx, A., et al. “Onchocerciasis Associated Epilepsy : An Important Neglected Public Health Problem”. Seizure: European Journal of Epilepsy, vol. 60, 2018, pp. 205–05, https://doi.org/10.1016/J.SEIZURE.2018.01.006 .
  • Dusabimana, A., et al. “Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy : A Three-country Short Cohort Study”. Pathogens, vol. 9, no. 8, 2020, https://doi.org/10.3390/PATHOGENS9080617 .
  • Siewe Fodjo, J. N., et al. Epidemiology and Clinical Characteristics of Onchocerciasis-associated Epilepsy. University of Antwerp, Faculty of Medicine and Health Sciences, Department of Epidemiology and Social Medicine, 2020.
  • Hotterbeekx, A., et al. “Comparison of Diagnostic Tests for Onchocerca Volvulus in the Democratic Republic of Congo”. Pathogens, vol. 9, no. 6, 2020, https://doi.org/10.3390/PATHOGENS9060435 .
  • Mandro, M., et al. “Ivermectin as an Adjuvant to Anti-epileptic Treatment in Persons with Onchocerciasis-associated Epilepsy: A Randomized Proof-of-concept Clinical Trial”. Plos Neglected Tropical Diseases, vol. 14, no. 1, 2020, pp. 1–6, https://doi.org/10.1371/JOURNAL.PNTD.0007966 .
  • de Smet, E., et al. Focus of Ongoing Onchocerciasis Transmission Close to Bangui, Central African Republic. no. 5, 2020, https://doi.org/10.3390/PATHOGENS9050337 .
  • Abd-Elfarag, G., et al. “Persons with Onchocerciasis-associated Epilepsy and Nodding Seizures Have a More Severe Form of Epilepsy with More Cognitive Impairment and Higher Levels of Onchocerca Volvulus Infection”. Epileptic Disorders, vol. 22, no. 3, 2020, pp. 301–08, https://doi.org/10.1684/EPD.2020.1164 .
  • Velghe, S., et al. “Dried Blood Microsampling-based Therapeutic Drug Monitoring of Antiepileptic Drugs in Children with Nodding Syndrome and Epilepsy in Uganda and the Democratic Republic of the Congo”. Therapeutic Drug Monitoring, vol. 42, no. 3, 2020, pp. 481–90, https://doi.org/10.1097/FTD.0000000000000720 .
  • Lakwo, T. L., et al. “The Role of the Maridi Dam in Causing an Onchocerciasis-associated Epilepsy Epidemic in Maridi, South Sudan : An Epidemiological, Sociological, and Entomological Study”. Pathogens, vol. 9, no. 4, 2020, pp. 1–3, https://doi.org/10.3390/PATHOGENS9040315 .
  • Hotterbeekx, A., et al. “From Nodding Syndrome to Onchocerciasis-associated Epilepsy”. Revue Neurologique, vol. 176, no. 5, 2020, pp. 405–06, https://doi.org/10.1016/J.NEUROL.2019.12.011 .
  • Dolo, H., et al. Onchocerciasis and Lymphatic Filariasis in Mali : Preparedness for Mass Drug Administration Interruption and Morbidity Management. University of Antwerp, Faculty of Medicine and Health Sciences, 2020.
  • Mandro, M., et al. Single Versus Multiple Dose Ivermectin Regimen in Onchocerciasis-infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo. -, 2019, https://doi.org/10.5281/ZENODO.3564280 .
  • Mandro, M., et al. Ivermectin as an Adjuvant to Anti-epileptic Treatment in Persons with Onchocerciasis-associated Epilepsy : A Randomized Proof-of-concept Clinical Trial. -, 2019, https://doi.org/10.5281/ZENODO.3562485 .
  • Mandro, M., et al. “Single Versus Multiple Dose Ivermectin Regimen in Onchocerciasis-infected Persons with Epilepsy Treated with Phenobarbital : A Randomized Clinical Trial in the Democratic Republic of Congo”. Pathogens, vol. 9, no. 3, 2020, pp. 1–8, https://doi.org/10.3390/PATHOGENS9030205 .
  • Hotterbeekx, A., et al. “Urinary N-acetyltyramine-o,beta-glucuronide in Persons with Onchocerciasis-associated Epilepsy”. Pathogens, vol. 9, no. 3, 2020, pp. 1–0, https://doi.org/10.3390/PATHOGENS9030191 .
  • Van Hees, S., et al. “Safety of Ivermectin During Pregnancy”. The Lancet Global Health, vol. 8, no. 3, 2020, pp. E338–38, https://doi.org/10.1016/S2214-109X(19)30555-8 .
  • Fodjo, J. N. S., et al. “Low Ivermectin Use Among 5-to 6-year-old Children : Observations from Door-to-door Surveys in Onchocerciasis-endemic Regions in Africa”. International Health, vol. 12, no. 1, 2020, pp. 72–75, https://doi.org/10.1093/INTHEALTH/IHZ044 .
  • Gumisiriza, N., et al. “Prevalence and Incidence of Nodding Syndrome and Other Forms of Epilepsy in Onchocerciasis-endemic Areas in Northern Uganda After the Implementation of Onchocerciasis Control Measures”. Infectious Diseases of Poverty, vol. 9, no. 1, 2020, pp. 1–1, https://doi.org/10.1186/S40249-020-0628-3 .
  • Hotterbeekx, A., et al. “Onchocerca Volvulus Is Not Detected in the Cerebrospinal Fluid of Persons with Onchocerciasis-associated Epilepsy”. International Journal of Infectious Diseases, vol. 91, 2020, pp. 119–23, https://doi.org/10.1016/J.IJID.2019.11.029 .
  • Siewe Fodjo, J. N., et al. “Epilepsy Prevention”. The Lancet : International Edition, vol. 394, no. 10214, 2019, pp. 2072–72, https://doi.org/10.1016/S0140-6736(19)31906-3 .
  • Colebunders, R., et al. “Ivermectin Use in Children Below 15 Kg : Potential Benefits for Onchocerciasis and Scabies Elimination Programmes”. British Journal of Dermatology, 2019, https://doi.org/10.1111/BJD.18685.
  • Menon, S., et al. “Women with Epilepsy in Sub–saharan Africa : A Review of the Reproductive Health Challenges and Perspectives for Management”. Seizure: European Journal of Epilepsy, vol. 71, 2019, pp. 312–17, https://doi.org/10.1016/J.SEIZURE.2019.08.016 .
  • Bhwana, D., et al. “Clinical Presentation of Epilepsy in Six Villages in an Onchocerciasis Endemic Area in Mahenge, Tanzania”. Epileptic Disorders, vol. 21, no. 5, 2019, pp. 425–35, https://doi.org/10.1684/EPD.2019.1093 .
  • Colebunders, R., et al. “Elimination of Onchocerciasis in Africa by 2025 : An Ambitious Target Requires Ambitious Interventions”. Infectious Diseases of Poverty, vol. 8, no. 1, 2019, https://doi.org/10.1186/S40249-019-0593-X .
  • Hotterbeekx, A., et al. “Neuroinflammation and Not Tauopathy Is a Predominant Pathological Signature of Nodding Syndrome”. Journal of Neuropathology and Experimental Neurology, vol. 78, no. 11, 2019, pp. 1049–58, https://doi.org/10.1093/JNEN/NLZ090 .
  • Bhwana, D., et al. “Nodding syndrome : close to solving the mystery”. The pediatric infectious disease journal, vol. 38, no. 11, 2019, https://doi.org/10.1097/INF.0000000000002442 .
  • Colebunders, R., et al. “Increased Cost-benefit of Strengthening Onchocerciasis Elimination Efforts in Areas with High Onchocerciasis-associated Epilepsy”. Tropical Medicine and International Health, 2019, https://doi.org/10.1111/TMI.13300 .
  • Siewe Fodjo, J. N., et al. “Would Ivermectin for Malaria Control Be Beneficial in Onchocerciasis-endemic Regions?”. Infectious Diseases of Poverty, vol. 8, no. 1, 2019, https://doi.org/10.1186/S40249-019-0588-7 .
  • Siewe Fodjo, J. N., et al. “Onchocerciasis-associated Epilepsy in the Democratic Republic of Congo: Clinical Description and Relationship with Microfilarial Density”. Plos Neglected Tropical Diseases, vol. 13, no. 7, 2019, https://doi.org/10.1371/JOURNAL.PNTD.0007300 .
  • Colebunders, R., et al. “From River Blindness to River Epilepsy: Implications for Onchocerciasis Elimination Programmes”. Plos Neglected Tropical Diseases, vol. 13, no. 7, 2019, https://doi.org/10.1371/JOURNAL.PNTD.0007407 .
  • Fodjo, J. N. S., et al. “Epidemiological Evidence Concerning the Association Between Onchocerciasis and Epilepsy”. International Journal of Infectious Diseases, vol. 82, 2019, pp. 77–78, https://doi.org/10.1016/J.IJID.2019.03.015 .
  • O'Neill, S., et al. “Stigma and Epilepsy in Onchocerciasis-endemic Regions in Africa: A Review and Recommendations from the Onchocerciasis-associated Epilepsy Working Group”. Infectious Diseases of Poverty, vol. 8, 2019, https://doi.org/10.1186/S40249-019-0544-6 .
  • Kaiser, C., et al. “Onchocerciasis-associated Epilepsy: Another Piece in the Puzzle from the Mahenge Mountains, Southern Tanzania”. Infectious Diseases of Poverty, vol. 8, 2019, https://doi.org/10.1186/S40249-019-0545-5 .
  • Boulle, C., et al. “Impact of 19 Years of Mass Drug Administration with Ivermectin on Epilepsy Burden in a Hyperendemic Onchocerciasis Area in Cameroon”. Parasites and Vectors, vol. 12, 2019, https://doi.org/10.1186/S13071-019-3345-7 .
  • Mandro, M., et al. “Onchocerca Volvulus as a Risk Factor for Developing Epilepsy in Onchocerciasis Endemic Regions in the Democratic Republic of Congo : A Case Control Study”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0465-9 .
  • Siewe Fodjo, J. N.and R. Colebunders. “Intervention for Reducing Epilepsy-associated Stigma”. Epilepsy and Behavior, vol. 90, 2019, pp. 295–95, https://doi.org/10.1016/J.YEBEH.2018.09.011 .
  • Siewe, J. F. N., et al. “Clinical Presentations of Onchocerciasis-associated Epilepsy (OAE) in Cameroon”. Epilepsy and Behavior, vol. 90, 2019, pp. 70–78, https://doi.org/10.1016/J.YEBEH.2018.11.008 .
  • Dolo, H., et al. “Integrated Seroprevalence-based Assessment of Wuchereria Bancrofti and Onchocerca Volvulus in Two Lymphatic Filariasis Evaluation Units of Mali with the SD Bioline Onchocerciasis/lf Igg4 Rapid Test”. Plos Neglected Tropical Diseases, vol. 13, no. 1, 2019, https://doi.org/10.1371/JOURNAL.PNTD.0007064 .
  • Siewe, J. N., et al. “Low Prevalence of Epilepsy and Onchocerciasis After More Than 20years of Ivermectin Treatment in the Imo River Basin in Nigeria”. Infectious Diseases of Poverty, vol. 8, 2019, https://doi.org/10.1186/S40249-019-0517-9 .
  • Mukendi, D., et al. “High Prevalence of Epilepsy in an Onchocerciasis Endemic Health Zone in the Democratic Republic of the Congo, Despite 14 Years of Community-directed Treatment with Ivermectin : A Mixed-method Assessment”. International Journal of Infectious Diseases, vol. 79, 2019, pp. 187–94, https://doi.org/10.1016/J.IJID.2018.10.021 .
  • Siewe Fodjo, J. N., et al. “Comprehensive Management of Epilepsy in Onchocerciasis-endemic Areas : Lessons Learnt from Community-based Surveys”. Infectious Diseases of Poverty, vol. 8, 2019, https://doi.org/10.1186/S40249-019-0523-Y .
  • Colebunders, R., et al. “High Prevalence of Onchocerciasis-associated Epilepsy in Villages in Maridi County, Republic of South Sudan : A Community-based Survey”. Seizure: European Journal of Epilepsy, vol. 63, 2018, pp. 93–101, https://doi.org/10.1016/J.SEIZURE.2018.11.004 .
  • Colebunders, R., et al. “Clinical Characteristics of Onchocerciasis-associated Epilepsy in Villages in Maridi County, Republic of South Sudan”. Seizure: European Journal of Epilepsy, vol. 62, 2018, pp. 108–15, https://doi.org/10.1016/J.SEIZURE.2018.10.004 .
  • Siewe Fodjo, J. N., et al. “Epidemiology of Onchocerciasis-associated Epilepsy in the Mbam and Sanaga River Valleys of Cameroon : Impact of More Than 13years of Ivermectin”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0497-1 .
  • Dolo, H., et al. “Community Perceptions of Epilepsy and Its Treatment in an Onchocerciasis Endemic Region in Ituri, Democratic Republic of Congo”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0498-0 .
  • Chesnais, C. B., et al. “The Temporal Relationship Between Onchocerciasis and Epilepsy : A Population-based Cohort Study”. The Lancet Infectious Diseases, vol. 18, no. 11, 2018, pp. 1278–86, https://doi.org/10.1016/S1473-3099(18)30425-0 .
  • Abd-Elfarag, G., et al. “The Effect of Bi-annual Community-directed Treatment with Ivermectin on the Incidence of Epilepsy in Onchocerciasis Endemic Villages in South Sudan: A Study Protocol”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0496-2 .
  • Melchers, N. V. S. V., et al. “Burden of Onchocerciasis-associated Epilepsy: First Estimates and Research Priorities”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0481-9 .
  • Lenaerts, E., et al. “High Prevalence of Epilepsy in Onchocerciasis Endemic Health Areas in Democratic Republic of the Congo”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0452-1 .
  • Greter, H., et al. “Evolution of Epilepsy Prevalence and Incidence in a Tanzanian Area Endemic for Onchocerciasis and the Potential Impact of Community-directed Treatment with Ivermectin : A Cross-sectional Study and Comparison over 28 Years”. BMJ Open, vol. 8, no. 3, 2018, https://doi.org/10.1136/BMJOPEN-2017-017188 .
  • Mmbando, B. P., et al. “High Prevalence of Epilepsy in Two Rural Onchocerciasis Endemic Villages in the Mahenge Area, Tanzania, After 20 Years of Community Directed Treatment with Ivermectin”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0450-3 .
  • Hotterbeekx, A., et al. “Histological Examination of Post-mortem Brains of Children with Nodding Syndrome”. Annals of Translational Medicine, vol. 6, no. 7, 2018, https://doi.org/10.21037/ATM.2018.02.04.
  • Colebunders, R., et al. “Report of the First International Workshop on Onchocerciasis-associated Epilepsy”. Infectious Diseases of Poverty, vol. 7, 2018, https://doi.org/10.1186/S40249-018-0400-0 .
  • Hendy, A., et al. “The Blackfly Vectors and Transmission of Onchocerca Volvulus in Mahenge, South Eastern Tanzania”. Acta Tropica, vol. 181, 2018, pp. 50–59, https://doi.org/10.1016/J.ACTATROPICA.2018.01.009 .
  • Colebunders, R., et al. “Onchocerciasis-associated Epilepsy, an Additional Reason for Strengthening Onchocerciasis Elimination Programs”. Trends in Parasitology, vol. 34, no. 3, 2018, pp. 208–16, https://doi.org/10.1016/J.PT.2017.11.009 .
  • Levick, B., et al. “High Prevalence of Epilepsy in Onchocerciasis Endemic Regions in the Democratic Republic of the Congo”. Plos Neglected Tropical Diseases, vol. 11, no. 7, 2017, https://doi.org/10.1371/JOURNAL.PNTD.0005732 .
  • Colebunders, R.and M. J. Titulaer. “Nodding Syndrome : Preventable and Treatable”. Science Translational Medicine, vol. 9, no. 377, 2017, https://doi.org/10.1126/SCITRANSLMED.AAM8532 .
  • Colebunders, R. L., et al. “Nodding Syndrome, Other Forms of Epilepsy, and the Nakalanga Syndrome Most Likely Directly or Indirectly Caused by Onchocerca Volvulus”. Journal of the Neurological Sciences, vol. 372, 2017, pp. 439–40, https://doi.org/10.1016/J.JNS.2016.10.008 .
  • Colebunders, R., et al. “Risk Factors for Epilepsy in Bas-uele Province, Democratic Republic of the Congo : A Case-control Study”. International Journal of Infectious Diseases, vol. 49, 2016, pp. 1–8, https://doi.org/10.1016/J.IJID.2016.05.018 .
  • Colebunders, R., et al. “Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo”. Plos Neglected Tropical Diseases, vol. 10, no. 5, 2016, https://doi.org/10.1371/JOURNAL.PNTD.0004478 .
  • Colebunders, R., et al. “Nodding Syndrome in Onchocerciasis Endemic Areas”. Trends in Parasitology, vol. 32, no. 8, 2016, pp. 581–83, https://doi.org/10.1016/J.PT.2016.05.013 .
  • Colebunders, R., et al. “Nodding Syndrome : We Can Now Prevent It”. International Journal of Infectious Diseases, vol. 44, 2016, pp. 61–63, https://doi.org/10.1016/J.IJID.2016.01.016 .
  • Colebunders, R., et al. “Nodding Syndrome and Epilepsy in Onchocerciasis Endemic Regions: Comparing Preliminary Observations from South Sudan and the Democratic Republic of the Congo with Data from Uganda”. BMC Research Notes, vol. 9, 2016, pp. 1–9, https://doi.org/10.1186/S13104-016-1993-7 .
  • Wamala, J. F., et al. “Nodding Syndrome May Be Only the Ears of the Hippo”. Plos Neglected Tropical Diseases, vol. 9, no. 8, 2015, https://doi.org/10.1371/JOURNAL.PNTD.0003880 .
  • Colebunders, R., et al. “Nodding Syndrome-a New Hypothesis and New Direction for Research”. International Journal of Infectious Diseases, vol. 27, 2014, pp. 74–77, https://doi.org/10.1016/J.IJID.2014.08.001 .
  • Colebunders, R., et al. “Nodding Syndrome Since 2012 : Recent Progress, Challenges and Recommendations for Future Research”. Tropical Medicine and International Health, vol. 20, no. 2, 2015, pp. 194–200, https://doi.org/10.1111/TMI.12421 .